Attached files

file filename
S-1/A - AMENDMENT TO FORM S-1 - Emmaus Life Sciences, Inc.v244889_s1a.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM

We hereby consent to the use of our report dated December 21, 2011 with respect to the consolidated financial statements of CNS Response, Inc. and its subsidiaries which expresses an unqualified opinion and includes an explanatory paragraph relating to a going concern uncertainty for the two-year period ended September 30, 2011, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
 
 /s/ Cacciamatta Accountancy Corporation
 
CACCIAMATTA ACCOUNTANCY CORPORATION
   
Irvine, California
 
January 13, 2012